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Abstract
Background: The role of p53 in the prevention of development of embryos damaged by genotoxic factors is well
recognized. However, whether p53 plays an analogous role in preventing birth defects from genetic mutations remains an
unanswered question. Genetic screens for mutations affecting development show that only a fraction of developmentally
lethal mutations leads to specific phenotypes while the majority results in similar recurrent phenotypes characterized by
neuronal apoptosis and developmental delay. Mutations in cell-essential genes typically fall into this group. The observation
that mutations in diverse housekeeping genes lead to a similar phenotype suggests a common mechanism underlying this
phenotype. For some mutants, p53 inhibition was shown to attenuate the phenotype.
Methodology/Principal Findings: To find out how common p53 involvement is in this phenotype, we analyzed zebrafish
mutants from various categories of cell essential genes. Several thousand zebrafish mutants have been identified; many of
them are kept at stock centers and available for the research community. We selected mutants for genes functioning in DNA
replication, transcription, telomere maintenance, ribosome biogenesis, splicing, chaperoning, endocytosis, and cellular
transport. We found that mutants have similar phenotypes including neural apoptosis, failure to develop structures
originated from the neural crest cells, and hematopoietic defects. All mutants share p53 upregulation and similar changes in
several p53-dependent and independent molecular pathways.
Conclusion/Significance: Our results suggest that mutations in housekeeping genes often canalize on the p53-mediated
phenotype. p53 prevents the development of embryos with defects in such genes. p53-mediated changes in gene
expression may also contribute to many human congenital malformations.
Citation: Danilova N, Kumagai A, Lin J (2010) p53 Upregulation Is a Frequent Response to Deficiency of Cell-Essential Genes. PLoS ONE 5(12): e15938.
doi:10.1371/journal.pone.0015938
Editor: Mikhail V. Blagosklonny, Roswell Park Cancer Institute, United States of America
Received October 19, 2010; Accepted November 30, 2010; Published December 31, 2010
Copyright:  2010 Danilova et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Diamond Blackfan Anemia Foundation and the National Institutes of Health research grant R01HL97561. The funders
had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: ndanilova@ucla.edu
Introduction
Some time ago, Hall and Lane suggested that the ability of p53
to prevent teratogenesis was the primary driving force behind the
evolution of this protein mainly known as a tumor suppressor [1].
The ‘‘guardian of the babies’’ idea was inspired by several reports
indicating that p53 decreases the level of congenital abnormalities
in experimental animals exposed to drugs or radiation [2,3]. For
example, X-ray irradiation of pregnant wild type mice leads to a
20% incidence of anomalies and a 60% incidence of death in
embryos, while in p532/2 mice the incidence of anomalies
increases to 70% and the frequency of death decreases to 7% [3].
Thus, activation of p53 in response to genotoxic stress promotes
the death of damaged embryos, and in this way, decreases the
incidence of congenital defects among the survivors.
In humans, about half of all pregnancies end in spontaneous
abortions early in development, while in mice the incidence of
sporadic death is 20–25% [4]. Embryonic death can be caused by
both environmental and genetic factors. The results of mutagenesis
screens suggest that disruption of 1,400 to 2,400 genes could lead
to early embryonic death in zebrafish [5]. These development-
essential genes tend to be evolutionarily conserved.
Of the mutations affecting zebrafish development, only about
one-third leads to relatively specific developmental defects while
the majority lead to more general and recurring phenotypes
manifested by increased neuronal necrosis/apoptosis and devel-
opmental delay. For this reason, of the more than 6,600 mutations
identified in mutagenesis screens in 1996, only 1740 were
maintained while others were discarded as ‘‘non-specific’’ [6,7].
In the screen performed at the Hopkins’ lab, all mutants with
visible embryonic phenotypes were maintained regardless of
specificity [5]. Therefore, these mutants represent a valuable
recourse to study the mechanisms underlying the non-specific
phenotype.
From mutants in the above study about half had non-specific
phenotype with neuronal apoptosis. In most cases, this phenotype
was associated with a mutation in a housekeeping gene. Next, we
analyzed the status of the p53 network in randomly selected
mutants from various categories of housekeeping genes and found
that they all had p53 upregulation. p53 upregulation was
especially pronounced in neural cells and p53 inhibition reduced
neuronal apoptosis. The mutants with upregulated p53 network
had similar changes in several p53-dependent and independent
molecular pathways. Therefore, p53-mediated changes may
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p53 may provide a checkpoint for development by integrating
genetic and environmental information. It prevents the develop-
ment of defective embryos beyond the early stages, thereby
preserving genomes at the population level.
Results
Mutants for cell-essential genes have similar phenotypes
Among 315 mutants identified in the Hopkins’ screen (see
supplemental table 3 in [5]), 157 have a similar phenotypic
signature, characterized by various degrees of brain necrosis at day
one, and at later stages, by a smaller head and eyes and
developmental delay. Analysis of genes affected in these mutants
showed that they encode proteins involved in ribosome biogenesis
(31%), chromatin maintenance, DNA replication and repair
(17%), transcription (9%), mRNA processing (14%), protein
folding and degradation, and other basic cellular functions. The
observation that mutations in diverse housekeeping genes lead to a
similar phenotype suggests a common mechanism underlying this
phenotype.
tp53 is upregulated in mutants for cell-essential genes
Previously, a number of isolated reports showed p53 upregula-
tion in response to deficiencies of some genes, which can be
classified as housekeeping. For example, mutations in several genes
involved in DNA replication and repair were associated with p53
upregulation [8,9]. We have recently found that zebrafish mutants
for ribosomal proteins (RPs) rps8, rps11, rps18, and rpl11 have
upregulation of the p53 network [10,11]. Mutations in some other
genes involved in ribosomal biogenesis also led to p53 upregula-
tion [12,13]. Upregulation of p53 was also noted in a mutant for
recycling factor p110 [14]. Notably that the phenotype charac-
terized by excessive neuronal apoptosis can be induced in
zebrafish by activating p53 through various treatments [15,16].
Altogether, these data suggest that p53 may mediate non-specific
phenotype of mutants for housekeeping genes.
To verify this hypothesis, we examined the p53 network in
randomly selected zebrafish mutants from various categories of
cell-essential genes. Genes affected in these mutants function in
splicing (u2af1, small nuclear RNA auxiliary factor), chaperoning
(hspa8, heat shock protein 8), endocytosis (clint1, clathrin interactor
1), ribosome biogenesis (heatr1, HEAT repeat containing, BAP-28
like), DNA replication (top2a, DNA topoisomerase II-alpha),
Figure 1. Phenotype of mutants for housekeeping genes are similar and depend on p53 network upregulation. A–C) Excessive neural
apoptosis was manifested as gray areas in the brain at 24 hpf, which was rescued by p53 inhibition D–F) At 48 hpf, there were more apoptotic cells in
mutants compared to siblings and p53 inhibition led to a decrease in apoptosis. Acridine orange staining. G–I) There were fewer erythroid cells in
mutants compared to siblings, which was rescued by p53 inhibition. o-dianizidine staining, 84 hpf, arrow points to erythrocytes. K–L) tp53
upregulation was higher in the brain and blood cells, 48 hpf, in situ hybridization, arrow points to erythrocytes.
doi:10.1371/journal.pone.0015938.g001
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transcription (snw1, SNW domain containing 1), and transport
(atp1a1, ATPase, Na+/K+ transporting, alpha 1 polypeptide). We
found tp53 upregulation in all these mutants.
The mutants had similar phenotype with prominent neuronal
apoptosis as shown by example of heatr1 mutant. At 24 hours post
fertilization, mutants’ brains had dark cloudy areas with blurred
midbrain-hindbrain boundaries (Fig. 1A,B). Acridine orange
staining showed that at 48 hpf, when wild-type embryos have very
few apoptotic cells, such cells were abundant in mutants, especially
in brains (Fig. 1D,E). The other tissue affected in the mutants was
blood; the mutants had fewer blood cells at 72 hpf (Fig. 1G,H). In
accord with these data, tp53 was upregulated the most in neural
and blood cells (Fig. 1K,L).
Inhibition of p53 by a morpholino prevented neural apoptosis in
the mutants (Fig. 1C,F). The anemia in the mutants was also
rescued by p53 inhibition (Fig. 1I). These data suggest that
phenotypic changes observed in the mutants were in large part
mediated by p53.
The levels of p53 upregulation varied between mutants. At 48 hpf,
thestrongestupregulationwasobservedinthe u2af1 mutant, followed
by hsp8 and top2a mutants (Fig. 2A). Along with the upregulation of
full-length tp53, we noted an upregulation of a truncated isoform,
D113p53 (Fig. 2B). This isoform is a part of the p53 autoregulatory
loop, it is p53 target and p53 inhibitor. Expression of this isoform is a
sensitive indicator of the activated p53 network.
Mutants have similar changes in several p53-dependent
and independent molecular pathways
Among p53-dependent pathways, the most important are those
mediating cell cycle arrest and apoptosis. In all mutants included in
this study, p53 targets responsible for cell cycle arrest such as cdkn1a
(p21) and ccng1 (cyclin G1) were upregulated (Fig. 2C,D) as well as
pro-apoptotic p53 targets such as puma and bax (Fig. 2E,F). The
activation of p53 targets was not directly proportional to the
upregulation levels of tp53. For example, cell cycle suppressor p21
was upregulated the most in the u2af1 and terfa mutants, while pro-
apoptotic puma was upregulated the most in the top2a and snw1.
Therefore phenotypic changes induced in these mutants by
upregulation of these p53 targets would be similar but not identical.
Another p53-dependent change found in the mutants examined
in this study was alteration in metabolism. It was manifested in a
shift in energy production from glycolysis to aerobic respiration; the
expression of glycolytic enzymes was suppressed (Fig. 3) This
observation is in accordance with cell lines data in which the ratio of
ATP produced by glycolysis versus aerobic respiration depended on
p53 dosage [17]. We also found shift from glycolysis to aerobic
respiration in the rpl11 mutant [11]. Increase in aerobic respiration
may lead to an increase in ROS production. In addition, enzymes
detoxifying ROS such as catalase, were downregulated in the
mutants (data not shown). Therefore, mutants with p53 upregula-
tion are likely to suffer from oxidative stress.
Another important metabolic change noted in the mutants with
p53 activation was downregulation of biosynthesis and activation
of catabolism. This affected many aspects of cellular homeostasis.
For example, a structural protein tuba2 was downregulated
(Fig. 4A) while mmp9 enzyme was upregulated (Fig. 4B). The
rpl11 mutant had similar changes [11].
Neural genes such as nrd were especially strongly suppressed
(Fig. 4C). They included genes specific for the neural crest cells,
such as tfap2 (Fig. 4D). Accordingly, the mutants formed only
rudiments of structures such as the craniofacial skeleton that
originates from the neural crest cells (Fig. 4E). The primitive wave
of blood cells formed normally in mutants, later, however, mutants
lost these cells (Fig. 1G,H) and the development of the definitive
wave of blood cells was suppressed as it was illustrated by the
decreased number of cells expressing runx1, a marker for
hematopoietic stem cells (Fig. 4F–G).
In addition to the p53 network, other stress response pathways
became activated in the mutants. They include immediate early
genes such as fos, a component of the AP1 factor functioning in the
JNK/p38 stress response pathway (Fig. 5A), genes involved in the
Figure 2. tp53 and its targets were upregulated in all studied mutants. A) The level of tp53 upregulation varied between mutants. B)
D113tp53 is a p53 target and p53 inhibitor, a part of p53 autoregulatory loop. C–D) Cell cycle suppressor cdkn1a (p21) and cyclin G1 were
upregulated. E–F) Pro-apoptotic puma and bax were upregulated in mutants. 48 hpf, qPCR.
doi:10.1371/journal.pone.0015938.g002
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and complement systems (Fig. 5C). Activation of the stress
response also took place at the hormonal level. The pituitary
responds to stress by increasing the production of pro-opiomela-
nocortin (Pomc) precursor polypeptide, which gives rise to several
peptides including ACTH (Fig. 5D).
Discussion
We analyzed the status of the p53 network in various mutants
for cell-essential genes. The genes affected in these mutants
function in diverse cellular processes, yet their disruption
universally leads to p53 upregulation. It is known that p53 can
be activated by various stress signals. p53 response to DNA
damage was especially thoroughly studied. Deficiency of several
factors involved in DNA replication and repair such as DNA ligase
IV was shown to lead to embryonic lethality mediated by p53
pathway [8]. Recently, we and others demonstrated p53
involvement in embryonic death caused by deficiency of ribosomal
proteins and other factors involved in ribosome biogenesis. Our
study suggests that p53 mediates embryonic lethality caused by
deficiency of genes involved in many more basic cellular functions
Figure 4. In mutants, biosynthesis was generally suppressed and catabolism was activated. A) Expression of structural proteins was
downregulated; tuba2 is shown as an example. B) Expression of catabolizing enzymes was upregulated; mmp9 is shown as an example. C) Expression
of neural genes was especially strongly suppressed in mutants; nrd is an example of a downregulated neural gene. D) Expression of a neural crest cell
marker tfap2 was downregulated. E) Only rudiments of the head skeleton derived from neural crest cells were present in the mutants. Alcian blue.
Day 4. F) Upregulation of p53 affects blood development; HSC marker runx1 was downregulated in the mutants; u2af1 mutant is shown as an
example.
doi:10.1371/journal.pone.0015938.g004
Figure 3. The mutants had shift in energy production to
aerobic respiration with supression of glycolysis. Examples in
changes in expression of 6-phosphofructokinase, muscle (pfkm) and
triosephosphate isomerase 1a(tpi1a) are shown. 48 hpf, qPCR.
doi:10.1371/journal.pone.0015938.g003
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function, chaperoning, and transport.
Altogether, these data supports the idea of a p53-based
developmental checkpoint. It seems that this checkpoints can be
triggered by both genotoxic factors and genetic defects (Fig. 6).
p53 is highly expressed in the early embryo [15,18], which
correlates with the high sensitivity of embryonic cells to stressors.
Irradiation at doses that have no effects in adult tissues cause p53-
dependent apoptosis in embryonic cells [19]. Embryos are
especially hypersensitive during gastrulation. In general, maximal
p53 activation was found in rapidly proliferating, non-differenti-
ated cells [18]. As the embryo becomes older, p53-mediated
response to stressors becomes weaker and more tissue-specific.
Blood and hair follicles preserve high p53 responsiveness in
adulthood [20].
Anti-teratogenic function of p53 in embryos seems to be a part
of a broader function of p53 and members of p53 family p63 and
p73 in controlling fidelity of reproduction. It ranges from
preserving the integrity of germ cells to regulation of implantation
[21], and to early embryonic development.
Apoptotic death in response to p53 activation is not the only
possible result of p53 activation in the embryo. In general, the
outcome of p53 activation such as apoptosis, senescence, or cell
cycle arrest depends on many factors including p53 dosage and
the type of cellular defect [22]. The choice between irreversible
senescence and reversible quiescence depends on p53 levels and
involves mTOR pathway so that inhibition of mTOR promotes
quiescence [23,24]. Haploinsufficiency of the mouse Rps6 gene
leads to the impairment of ribosome biogenesis, high p53
activation and early embryonic death [25]. In contrast, some
hypomorphic mutations in ribosomal proteins that cause lower
degree of p53 activation are not embryonically lethal [26,27]. In
fact, in the Rpl24-deficient mouse embryos, p53 plays pro-
survival role, which was suggested to depend of p53 targets
inducing cell cycle arrest [27]. mTOR inhibitor Sestrin 2 was
among strongly upregulated genes in Rpl24-deficient embryos,
which could promote quiescence in embryos helping them to
pass embryonic stages at slower pace decreasing the level of
cellular stress.
How is the p53-dependent developmental checkpoint activated
in embryos? A distinctive feature of early development is rapid cell
division, which takes about 15 minutes in zebrafish. Defects in cell-
essential genes slowing the embryo’s progression through devel-
opment may lead to increased mitogenic signaling. Indeed, such
increase was noted in the rpl11 mutant [11]. Enhanced delivery of
growth factor may lead to stalling of DNA replication forks and
double strand breaks (DSBs) [28]. Mitogens would activate the
Arf-p53 axis, while DSBs would signal to p53 through ATM
(ataxia telangiectasia mutated). In support, cells deficient in
telomeric repeat binding factor TRF2 activate p53 through
ATM signaling [29]. Moreover, in vitro depletion of splicing
factor ASF/SF2 also resulted in DSBs [30]. However, genetic
inactivation of p19Arf in RPS6-deficient mouse embryos does not
rescue the embryos and these embryos do not activate ATM
suggesting other pathways mediate p53 upregulation in this model
[25]. Therefore, the connection between cellular oncogenes and
p53 activation in mutants for housekeeping genes needs further
investigation.
Figure 5. In addition to p53, other stress response pathways were activated in the mutants. A) fos, a component of AP-1 factor was
upregulated. B) fibrinogen involved in acute phase response was upregulated. C) Innate immune mechanisms involving complement and interferon
systems were upregulated. D) pomc that encodes precursor of peptides involved in hypothalamo-pituitary-adrenal hormonal axis response was
upregulated.
doi:10.1371/journal.pone.0015938.g005
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sensor mediating p53 activation [31]. Some data support this idea,
while others do not [32]. Instead, activation of p53 in response to
defects in ribosome biogenesis was suggested to depend on RPs not
incorporated into ribosomes. Some RPs bind Mdm2 and activate
p53 in this way. All of these mechanisms, however possible, do not
explain the transcriptional upregulation of p53. Among possible
p53-transactivating factors are AP1 factor genes such as fos, myc
family, and NFkB. p53 promoter carries AP1-binding element,
Myc E-box DNA binding motif, and NFkB binding site [33].
Involvement of other factors stabilizing tp53 mRNA also cannot be
excluded [34].
It is also possible that p53 activation in embryos with genetic
defects is a cumulative effect of several checkpoints merging at
p53. In any case, although p53 is acting at the cellular level, it may
ultimately provide an integrating checkpoint at the organism level
by preventing embryos with genetic defects, damaged, or stressed
from developing beyond the initial stages. The role of p53 at the
population level may indeed be similar to its ‘‘guardian of the
genome’’ role at the cellular level, where it removes defective cells
from the proliferating pool.
Our data suggest that mutations in hundreds of housekeeping
genes may result in the upregulation of the p53 network. This
means that the classic genotype – phenotype concept cannot be
applied to mutations in many housekeeping genes since the
resulting phenotype would depend on p53. In fact, many papers
have interpreted the phenotypic changes in mutants for house-
keeping genes as a proof that these genes are directly involved in
the development of a particular tissue. Especially alterations in the
development of brain, neural crest derivatives, and blood, which
are the most sensitive to p53 upregulation, can be easily
misinterpreted. Therefore, genotype-phenotype mapping should
take into account that a large proportion of genes would canalize
on a p53-dependent phenotype. The upregulation of p53 in
response to a deficiency of housekeeping genes may also account,
at least partially, for the phenomenon of frequent p53 activation
by various knockdown techniques [Robu, 2007 #2668].
While p53 seems to be a universal anti-teratogenic factor, there
is another side of p53. If, for any reason, embryos experience p53
upregulation but survive, they may carry the malformations
caused by p53 upregulation. Neural and blood cells are the most
sensitive targets. An example of p53-mediated pathology in
humans is Treacher Collins syndrome, which is caused by p53-
mediated apoptosis in neural crest cells [Jones, 2008 #3375].
p53 activation during early development induced by various
stressors may be the reason why human congenital anomalies
caused by diverse factors are similar. The p53 network may have a
much more important role in the origin of human congenital
malformations than it is currently appreciated. In the future,
evaluation of the p53 family status may become an informative
tool in prenatal diagnostics.
Materials and Methods
Ethics Statement
Zebrafish embryos were handled according to relevant national
and international guidelines.
UCLA office for protection of research subjects approved the
use of zebrafish (ARC # 2001-074-22).
Zebrafish
The following mutant lines have been used: u2af1
hi199Tg;
hspa8
hi138Tg; clint1
hi 1520Tg; terfa
hi3678Tg; snw1
hi296bTg; top2a
hi3635Tg;
heatr1
hi932Tg; atp1a1
m883/m883. Fish of the wild type TU and mutant
strains were reared at 28.5uC at a 14-hr light/10-hr dark cycle.
Embryos were obtained by natural spawning.
qRT-PCR
RNA was prepared using Trizol (Invitrogen, Carlsbad, CA)
from pool of 30–40 embryos. cDNA was synthesized by reverse
transcription of 2 mg of RNA with the random hexamer primers.
Quantative PCR (qPCR) was performed using iQ SYBR Green
Super Mix and a MyiQ Single-Color PCR thermal cycler (Biorad,
Hercules, CA). Each experiment was performed in triplicate.
Levels of mRNA expression in mutants relative to sibling controls
were normalized to beta-actin and calculated according to the Ct
method. Primer sequences are available upon request.
In situ hybridization
Whole mount in situ hybridization was carried out as described
[35] with tp53 and runx1 riboprobes.
Morpholinos
To inhibit p53, a previously described p53 morpholino 59-
gcgccattgctttgcaagaattg, inhibitor of translation, was used [15]
(Gene Tools, Corvallis, OR). The 3ng of morpholino was injected
at the one cell stage.
Figure 6. p53 integrates environmental and genetic informa-
tion into a developmental checkpoint. Each genetic alteration
would lead to specific changes in gene expression but changes
mediated by p53 may have a major impact on the resulting phenotype.
p53 activation can lead to embryonic death or malformations, therefore
p53 may in most cases prevent teratogenesis but induce it in other
cases. The outcome would depend on the degree of p53 activation,
type of stressor and the age and condition of the embryo.
doi:10.1371/journal.pone.0015938.g006
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